SWITCH THERAPEUTICS

In News

Sangamo looks to switch lenders midbankruptcy as it eyes a quick sale process - bizjournals.com

bizjournals.com - Jul 22, 2026

Targeting the ApoE4 Gene to Treat Alzheimer’s - Being Patient

Being Patient - Apr 07, 2026

Dual switches ignite tumour-specific mRNA therapeutics - Nature

Nature - Nov 12, 2025

Sanofi’s stunning CEO switch—Chutes & Ladders - Fierce Biotech

Fierce Biotech - Feb 13, 2026

Gene therapy ‘switch’ may offer non-addictive pain relief - Penn Medicine

Penn Medicine - Jan 07, 2026

Cancer – Switch Receptors to Advance Immunotherapy - Seattle Children’s Hospital

Seattle Children’s Hospital - Apr 10, 2026

Why Is Turn Therapeutics Stock Soaring Over 370% Premarket Today? - Stocktwits

Stocktwits - Oct 09, 2025

MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies - UT MD Anderson

UT MD Anderson - Sep 05, 2025

Switch Therapeutics launches with $52M to capitalize on RNA medicine ‘era’ - BioPharma Dive

BioPharma Dive - Mar 14, 2023

Switch Therapeutics Appoints David M. Holtzman, M.D., to Its Scientific Advisory Board and Announces Its First Development Candidate, CASi-APOE, a Liver-Sparing APOE RNAi Therapy - BioSpace

BioSpace - Dec 03, 2024

symbol__ Stock Quote Price and Forecast - CNN

CNN - Oct 08, 2025

Switch Therapeutics Launches to Develop Targeted siRNA Therapies - Inside Precision Medicine

Inside Precision Medicine - Mar 14, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment